Fee for scientific advice: classification of a medicinal product
5.—(1) The fee payable by a person with whom the licensing authority holds a meeting to provide scientific advice in connection with the classification of a relevant medicinal product, is—
(a)£2,986, if the advice relates to a product which, if reclassified, will be available on general sale; and
(b)£3,917, if the advice relates to a product which, if reclassified, will be available without a prescription from a pharmacy.
(2) For the purposes of this regulation, a product is on general sale if it is a medicinal product of a description or falling within a class specified in an Order made under section 51 (general sale lists) of the Act(1).
(1)
Amendments have been made to section 51 by S.I. 2006/2407.